Literature DB >> 17036198

Ceramide induces apoptosis via a peroxisome proliferator-activated receptor gamma-dependent pathway.

Jing Wang1, Xiaowen Lv, Jieping Shi, Xiaosong Hu.   

Abstract

Both of ceramide and PPARgamma ligand can trigger cancer cell apoptosis. We here show that C2-ceramide can modulate PPARgamma expression level and its transcriptional activity and results in apoptosis in HT29 cells. Administration of PPARgamma specific antagonist GW9662 partially prevents HT29 cells from apoptosis. Furthermore, MAP kinase pathway provided a potential modulation mechanism for PPARgamma pathway related with ceramide. Our results are the first to demonstrate that C2-ceramide induces apoptosis via a PPARgamma-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17036198     DOI: 10.1007/s10495-006-0191-9

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  5 in total

1.  Mechanisms involved in ceramide-induced cell cycle arrest in human hepatocarcinoma cells.

Authors:  Jing Wang; Xiao-Wen Lv; Jie-Ping Shi; Xiao-Song Hu
Journal:  World J Gastroenterol       Date:  2007-02-21       Impact factor: 5.742

Review 2.  The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signalling.

Authors:  Wilhelm Engström; Philippa Darbre; Staffan Eriksson; Linda Gulliver; Tove Hultman; Michalis V Karamouzis; James E Klaunig; Rekha Mehta; Kim Moorwood; Thomas Sanderson; Hideko Sone; Pankaj Vadgama; Gerard Wagemaker; Andrew Ward; Neetu Singh; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Anna Maria Colacci; Monica Vaccari; Chiara Mondello; A Ivana Scovassi; Jayadev Raju; Roslida A Hamid; Lorenzo Memeo; Stefano Forte; Rabindra Roy; Jordan Woodrick; Hosni K Salem; Elizabeth P Ryan; Dustin G Brown; William H Bisson
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

3.  PPARδ signaling mediates the cytotoxicity of DHA in H9c2 cells.

Authors:  Victor Samokhvalov; Igor Zlobine; Kristi L Jamieson; Paul Jurasz; Christopher Chen; Kin Sing Stephen Lee; Bruce D Hammock; John M Seubert
Journal:  Toxicol Lett       Date:  2014-10-06       Impact factor: 4.372

4.  Proton NMR-based metabolite analyses of archived serial paired serum and urine samples from myeloma patients at different stages of disease activity identifies acetylcarnitine as a novel marker of active disease.

Authors:  Alessia Lodi; Stefano Tiziani; Farhat L Khanim; Ulrich L Günther; Mark R Viant; Gareth J Morgan; Christopher M Bunce; Mark T Drayson
Journal:  PLoS One       Date:  2013-02-19       Impact factor: 3.240

5.  A novel PPARɣ ligand, PPZ023, overcomes radioresistance via ER stress and cell death in human non-small-cell lung cancer cells.

Authors:  Tae Woo Kim; Da-Won Hong; Chang-Mo Kang; Sung Hee Hong
Journal:  Exp Mol Med       Date:  2020-10-12       Impact factor: 8.718

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.